// App-Quantinova.ai

: Transcriptional Rewiring and Therapeutic Resistance in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Yang Y Ding

Principal Investigators

  • Joseph Patrick Loftus

  • Benjamin Mathier

  • Wenbao Yu

  • David Hottman Allen

  • Bing He

  • Catherine D Falkenstein

  • Sarah K Tasian

  • Kai Tan

Medical Centers

  • Pennsylvania State University College of Medicine, Hershey, PA

  • Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

  • Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA

  • Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Ruxolitinib phosphate

  • Venetoclax

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A